Only in Titles

Search results for: Rabbit anti VEGF-A pan (human)

paperclip

#21782909   2011/07/18 To Up

The evolution of alternative splicing exons in vascular endothelial growth factor A.

The C-terminus alternative splicing in VEGFA (vascular endothelial growth factor A) is known for its impact on physiological and pathological angiogenesis. Based on our prediction and RT-PCR verification, we identified anti-angiogenic VEGFA165b isoforms in mouse and rabbit for the first time. We also found that the relative expression level of VEGFA165b isoform had been increasing from rodents to human, and exon8b may have experienced a minor-to-major form exon conversion, possibly correlated with its gain-of-function. It is suggested that introduction of alternative splicing exons (esp. exon6 and exon8b) made important contributions to the transcriptional diversity of VEGFA and played a crucial role in the evolution of its regulatory mechanism.
Jiaxi Xu, Tonghai Dou, Cong Liu, Maobin Fu, Yan Huang, Shaohua Gu, Yan Zhou, Yi Xie

2039 related Products with: The evolution of alternative splicing exons in vascular endothelial growth factor A.

2ug2ug96T2ug2ug2ug5ug2ug x 2010ugProtein10ug100.00 ug

Related Pathways

paperclip

#7535859   // To Up

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.

Vascular endothelial growth factor (VEGF) is a secreted endothelial-specific growth factor that is angiogenic in vivo. It is commonly expressed in a range of carcinomas.
H T Zhang, P Craft, P A Scott, M Ziche, H A Weich, A L Harris, R Bicknell

1320 related Products with: Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.

2ug96T2ug2ug x 205ug2ug5 x 50 ug2ug50 ug2ug0.1 mg1.00 flask

Related Pathways